Estrogen receptor-α36 is involved in epigallocatechin-3-gallate induced growth inhibition of ER-negative breast cancer stem/progenitor cells

• Autors principals: Xiaohua Pan (Autor), Bowen Zhao (Autor), Zhen Song (Autor), Shuai Han (Autor), Molin Wang (Autor)
• Format: Llibre
• Publicat: Elsevier, 2016-02-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Epigallocatechin-3-gallate (EGCG) is a type of catechin extracted from green tea, which is reported to have anticancer effects. EGCG is also reported to inhibit the cancer stem/progenitor cells in several estrogen receptor (ER)-negative breast cancer cell lines, such as SUM-149, SUM-190 and MDA-MB-2...